Sentante
PrivateLast Round
Grant
Jul 9, 2024
Total Funding Raised
$9.63M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Sentante operates in Healthcare & Life Sciences and is based in Kaunas. Its latest recorded funding round was a Seed round in December 2023.
Sentante is a medical technology company that develops a fully robotic teleoperated system for endovascular interventions.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Industrial Robotics, Telemedicine, Medical Imaging
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sentante Comparables
Compare Sentante with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanoflex Robotics | 92% | |
| Remedy Robotics | 90% | |
| XCath | 89% |
For institutional investors. Book with your work email.
Sentante Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 9, 2024 | ||||
| Seed | Dec 21, 2023 | ||||
| Grant | Jun 16, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sentante Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Practica Capital | Seed |
| European Regional Development Fund | Grant |
| European Innovation Council Fund | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 122% MoM, reaching 1.2K.
- Aug 2, 2026
Grew 18% QoQ, from 33 to 39 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withAug 25, 2026
Sentante integrates NVIDIA Corporation's NVIDIA Jetson AGX platform into its latest-generation robot and is among the first to develop on NVIDIA Isaac for Healthcare.
For institutional investors. Book with your work email.
Sentante Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sentante's valuation, stock price, and market status.
Is Sentante a public or private company?
Sentante is a private company.
What is the current stock price of Sentante?
Sentante is a private company, so its shares have no public market price. Caplight tracks Sentante's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sentante worth (valuation)?
Valuation information for Sentante is not publicly available.
Can I buy Sentante stock?
Sentante shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sentante's last funding round?
Sentante's most recent funding round was Grant on July 9, 2024.
Who are the main investors in Sentante?
Key investors in Sentante include Practica Capital.
Will Sentante IPO soon?
No public IPO plans have been announced for Sentante.
How can I track Sentante secondary market activity?
Caplight tracks bids, offers, and trades in Sentante's shares on secondary markets.